GC Aesthetics Ltd. (GCA) has announced the launch of the next generation of GCA breast implants, PERLE.
GC Aesthetics launches new breast implant PERLE
PERLE is a novel Round Breast Implant with (R)evolutionary BioQ– Surface technology and highly cohesive Emunomic Breast Tissue Dynamic Gel.
Backed by GC Aesthetics’ global reputation for long-term safety, and more than three million implants sold over the last 10 years, PERLE gives patients and surgeons a new alternative for aesthetic and reconstruction procedures.
Carlos Reis Pinto, CEO at GC Aesthetics said: “With PERLE, we complete our range of breast implants to best suit each patient’s and plastic surgeon’s individual needs. We back our commitment of being a global medical device company focused on aesthetic surgery, women’s health and patient security through a broad portfolio of secure and innovative solutions.”
PERLE’s (R)evolutionary BioQ – Surface is developed with reverse surface technology. With this new surface, GC Aesthetics has taken advantage of the benefits associated with low surface roughness – such as reduced inflammation, easier placement and incision, as well as lower risk of capsular contracture.
PERLE’s exclusive Emunomic Breast Tissue Dynamic Gel is the first 6th generation gel which is highly cohesive, virtually unbreakable and gives projection, fullness and firmness.
GCA completes its offering to plastic, reconstructive and aesthetic surgeons with the launch.